Greenwich LifeSciences
GLSI
$14.83
Share price
10.59%
Change (1 day)
36.18%
Change (1 year)
Categories
Greenwich LifeSciences (GLSI) Fails to deliver data
Key failure to deliver metrics for Greenwich LifeSciences:
- Last SEC data release: 2024-05-14
- Last 15 days FTD volume: $0.01 M
- Last 3 months FTD volume: $0.84 M
- Last year FTD volume: $1.51 M
Failures to deliver for Greenwich LifeSciences (GLSI) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Greenwich LifeSciences (GLSI) - since 2020
Volume in USD (price x number of shares), data since 2020Greenwich LifeSciences (GLSI) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $0.94 M | -2.2% |
| 2023 | $0.96 M | -84.45% |
| 2022 | $6.22 M | -75.15% |
| 2021 | $25.06 M | -7.29% |
| 2020 | $27.03 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Organovo ONVO | $3.73 M | $4.34 M | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | N/A | $0.27 B | 🇬🇧 UK |
 Novavax NVAX | $48.41 M | $0.30 B | 🇺🇸 USA |
 Novocure
NVCR | $0.72 M | $7.09 M | Jersey |